[Federal Register Volume 91, Number 75 (Monday, April 20, 2026)]
[Notices]
[Page 21011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-07576]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the NIH Clinical Center
Research Hospital Board.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other reasonable accommodations should notify the Contact
Person listed below in advance of the meeting. The meeting can be
accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: June 12, 2026.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC) Leadership Announcements,
CC Acting Chief Executive Officer (CEO), Update of Recent Activities
and Organizational Priorities, and Other Business of the Clinical
Center Research Hospital Board (CCRHB).
Address: National Institutes of Health, Building 31, Conference
Room 6C02 A & B, 9000 Rockville Pike, Bethesda, MD 20892 (In-Person
and Virtual).
Meeting Format: In-person and Virtual Meeting.
Contact Persons: Patricia Piringer, RN, MSN (C), National
Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD
20892, [email protected], (301) 402-2435, (202) 460-7542
(direct).
Natascha Pointer, Management Analyst, Executive Assistant to Dr.
Gilman, Office of the Chief Executive Officer, National Institutes
of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892,
[email protected], (301) 496-4114, (301) 402-2434 (direct).
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://security.nih.gov/visitors/Pages/visitor-campus-access.aspx for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the CCRHB website: https://www.ccrhb.od.nih.gov/ where an agenda and any additional information
for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS).
Dated: April 14, 2026.
Margaret N. Vardanian,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-07576 Filed 4-17-26; 8:45 am]
BILLING CODE 4167-05-P